Catheter ablation for ventricular tachycardia in structural heart disease

Canadian Journal of Cardiology

Volumn 30, Issue 2, 2014, Pages 244-246

  MacIntyre, Ciorsti J ^a   Sapp, John L ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; SOTALOL;

ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CATHETER ABLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SHOCK; INTRACARDIAC ECHOCARDIOGRAPHY; ISCHEMIC CARDIOMYOPATHY; LIVER DISEASE; LUNG DISEASE; MORTALITY; MULTICENTER STUDY (TOPIC); MYOCARDIAL SCAR; NONHUMAN; NONISCHEMIC CARDIOMYOPATHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCAR; SHOCK; SKIN DISEASE; SUDDEN CARDIAC DEATH; THYROID DISEASE;

CATHETER ABLATION; HEART DISEASES; HUMANS; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 84892992167     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.11.015     Document Type: Article

References (4)

1. Dunbar S.B., Dougherty C.M., Sears S.F., et al. Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation 2012, 126:2146-2172.
2. Poole J.E., Johnson G.W., Hellkamp A.S., et al. Prognostic importance of defibrillator shocks in patients with heart failure. New Engl J Med 2008, 359:1009-1017.
3. Sweeney M.O., Sherfesee L., DeGroot P.J., Wathen M.S., Wilkoff B.L. Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. Heart Rhythm 2010, 7:353-360.
4. Moss A.J., Schuger C., Beck C.A., et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012, 367:2275-2283.